Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms Kerstin RöhssTore LindClive Wilder-Smith Pharmacodynamics 02 September 2004 Pages: 531 - 539
Electrocardiogram and cardiovascular changes in thioridazine and chlorpromazine poisoning E. M. StrachanC. A. KellyD. N. Bateman Pharmacodynamics 15 September 2004 Pages: 541 - 545
Fatal intoxication cases: cytochrome P 450 2D6 and 2C19 genotype distributions A. L. ZackrissonP. HolmgrenB. Lindblom Pharmacogenetics 02 September 2004 Pages: 547 - 552
Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine Kazushi SawamuraYutaro SuzukiToshiyuki Someya Pharmacogenetics 03 September 2004 Pages: 553 - 557
Effects of growth hormone deficiency and rhGH replacement therapy on the 6β-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children Blanca SinuésEsteban MayayoAngel Ferrández-Longás Pharmacogenetics 07 September 2004 Pages: 559 - 564
Premedication medicines do not cause drug metabolic interaction with propofol using human liver microsomes in vitro Einosuke TanakaYui TakanoKatsuya Honda Pharmacokinetics and Disposition 04 September 2004 Pages: 565 - 568
Pharmacokinetics and transplacental transfer of lidocaine and its metabolite for perineal analgesic assistance to pregnant women Ricardo de Carvalho CavalliVera Lúcia LanchoteSérgio Pereira da Cunha Pharmacokinetics and Disposition 07 September 2004 Pages: 569 - 574
Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes Kyoung-Ah KimJaegul ChungJi-Young Park Pharmacokinetics and Disposition 08 September 2004 Pages: 575 - 581
Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions Stanislav MicudaLucie MundlovaJirina Martinkova Pharmacokinetics and Disposition 16 September 2004 Pages: 583 - 589
Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema J. -L. MagnetteJ. -L. KienzlerA. Knops Pharmacokinetics and Disposition 29 September 2004 Pages: 591 - 594
Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany Verena BergkChristiane GasseWalter E. Haefeli Pharmacoepidemiology and Prescription 04 September 2004 Pages: 595 - 602
Protease inhibitors and diltiazem increase tacrolimus blood concentration in a patient with renal transplantation: a case report Gaëlle HardyFrançoise Stanke-LabesqueGermain Bessard Short Communication 15 September 2004 Pages: 603 - 605
A new opportunity for thalidomide? Further randomised controlled trial are necessary Federico MarchettiMarzia LazzeriniAlessandro Ventura Letter to the Editors 03 September 2004 Pages: 607 - 608